Event Details
ASCO GI 2021
Jan 15 2021
The 2021 Gastrointestinal (GI) cancers symposium will take place from January 15th to 17th and will offers new and innovating findings in GI cancer treatment, research, and care.
It will feature a wide array of topics delivered by experts in cancers of the esophagus, stomach, pancreas, small bowel, hepatobiliary tract, colon, rectum and anus.
Nanobiotix will be presenting data from the phase I dose-escalation study evaluating the potential of NBTXR3 for the treatment of HCC and liver metastases.
Agenda
We are proud to have one abstract approved for the digital poster presentation that would be release on the ASCO website on January 11, 2021 at 5:00pm (EST).
Presenting Author: Thierry de Baère
Abstract Number: 319
Abstract Title: Results from the phase I dose-escalation study of the radiation enhancer NBTXR3 for the treatment of HCC and liver metastases.
Session Information: Poster Session: Hepatobiliary Cancer